Amgen
在场
是其中之一......
- Forbes Global 2000 (#193);
- Fortune 500 (#151);
- Nasdaq 100;
- Russell 3000;
- S&P 500;
- TOB Iconic 10,000.
Amgen 是一家在股票代码 AMGN (US) 下上市的公司。
Amgen 在 21 个国家有直接业务。Amgen 拥有 24家子公司，其中包括 Amgen APAC、Amgen Argentina 和 Amgen Australia。
他们在：
涉及Amgen的并购和融资。
- Amgen Rare Disease and Amgen have announced they will merge (公布2023十月10号)..
- Amgen has announced the acquisition of Amgen Rare Disease (公布2022十二月12号).
高管
查看带有其 217 名主要高管的组织结构图
Amgen 搜索最多的简介
高管在Amgen变化
- Howard ChangHoward Chang 将于202412月16作为 Chief Scientific Officer and Senior Vice President of Research 加入公司 (新闻发布的2024十一月22号).
创建提醒
跟踪 Amgen 的高管变动
药店
Amgen 拥有 1,842 家竞争者，其中包括 Pfizer (美国(美洲))、Johnson & Johnson (美国(美洲)) 和 Sanofi (法国)。
Popular M&A news in 药店
- Stemtech and Seacret Direct have announced they will merge (公布2024十一月22号)..
- BeiGene将改名为BeOne Medicines。 (公布2024十一月15号).
- GlycoMimetics and Crescent Biopharma have announced they will merge (公布2024十一月15号)..
药店 行业的其他推荐联系人
消息
Amgen 的最新新闻稿
- AMGEN PRESENTS POSITIVE PHASE 3 DATA FOR UPLIZNA® (INEBILIZUMAB-CDON) IN GENERALIZED MYASTHENIA GRAVIS (GMG) AT AANEM 2024
- LA LA ANTHONY PARTNERS WITH AMGEN TO SHARE CANDID, BEHIND-THE-SCENES LOOK AT HOW PLAQUE PSORIASIS AFFECTS HER LIFE
- TEPEZZA® (TEPROTUMUMAB) RECEIVES APPROVAL IN JAPAN FOR THE TREATMENT OF ACTIVE THYROID EYE DISEASE
- AMGEN TO HOST CONFERENCE CALL TO DISCUSS NEW TOPLINE DATA IN INFLAMMATION AND RARE DISEASE
- AMGEN PRESENTS NEW DATA FOR FIRST-IN-CLASS IMDELLTRA™ (TARLATAMAB-DLLE) IN SMALL CELL LUNG CANCER AT WCLC 2024
- AMGEN TO PRESENT DATA FROM MULTIPLE EARLY-STAGE CLINICAL TRIALS AT ESMO 2024
- AMGEN TO PRESENT AT THE MORGAN STANLEY 22ND ANNUAL GLOBAL HEALTHCARE CONFERENCE
- AMGEN TO PRESENT AT THE 2024 WELLS FARGO HEALTHCARE CONFERENCE
- OTEZLA® (APREMILAST) NOW AVAILABLE IN THE U.S. FOR MODERATE TO SEVERE PEDIATRIC PLAQUE PSORIASIS
- AMGEN ANNOUNCES WEBCAST OF 2024 SECOND QUARTER FINANCIAL RESULTS
- View more press releases Close
通过电子邮件
